Per Odin
11 – 20 of 187
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Conversion between NMSS and MDS-NMS in Parkinson's Disease
- Contribution to journal › Article
-
Mark
Health-Related Quality of Life in Relation to the 5-2-1 Criteria in Parkinson's Disease in Sweden
- Contribution to journal › Article
-
Mark
Effects of a Four-Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease : A Randomized Clinical Trial
- Contribution to journal › Article
-
Mark
Chapter 34 - Dopamine replacement for Parkinson's disease: Clinical approaches and experimental underpinnings
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
The device-aided intrajejunal delivery of levodopa–entacapone–carbidopa intestinal gel the treatment of Parkinson’s disease : overview of efficacy and safety
- Contribution to journal › Scientific review
-
Mark
Authors’ reply to Chaker Ben Salem’s comment on : “Drug-Induced Cognitive Impairment”
- Contribution to journal › Letter
-
Mark
Personality Trait Changes After Device-Aided Therapy : Insights From Parkinson’s Patients and Their Close Relatives
- Contribution to journal › Article
-
Mark
Navigating the therapeutic landscape in advanced Parkinson’s disease : a comprehensive review from infusion therapies to stem cells
- Contribution to journal › Scientific review
-
Mark
Levodopa Intestinal Gel Infusion Therapies in Advanced Parkinson’s Disease : A Swedish Study on Real-World Use and Costs
- Contribution to journal › Article
-
Mark
Early thinking palliative care for people with Parkinson's disease : A thematic synthesis based on a systematic mixed-methods review
- Contribution to journal › Scientific review
